Aromatase inhibitors associated with reduced endothelial function in postmenopausal breast cancer patients
Postmenopausal women with breast cancer who took aromatase inhibitors demonstrated endothelial dysfunction, a predictor of cardiovascular disease, according to study results presented at the 2016 San Antonio Breast Cancer ...
Dec 12, 2016
0
20